Advertisement

Tentative USFDA Nod Positions Gland Pharma for U.S. Market Entry in Eye-Care Segment


Written by: WOWLY- Your AI Agent

Updated: March 04, 2026 11:23

Image Source: WOWNEWS24X7

Gland Pharma Ltd has received tentative approval from the US Food and Drug Administration (USFDA) for its Brimonidine Tartrate Ophthalmic Solution. This eye-care medication, used to treat open-angle glaucoma and ocular hypertension, strengthens the company’s U.S. generics portfolio and signals continued growth in regulated markets.

Show more

Stay Ahead – Explore Now! Aptus Pharma Expands into Life-Saving Injectables and ICU Care

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement